<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04070365</url>
  </required_header>
  <id_info>
    <org_study_id>AV2019</org_study_id>
    <nct_id>NCT04070365</nct_id>
  </id_info>
  <brief_title>FLEX Arteriovenous Access Registry</brief_title>
  <official_title>FLEX Arteriovenous Access Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VentureMed Group Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VentureMed Group Inc.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of the FLEX Vessel Prep system combined with angioplasty in the treatment of
      arteriovenous access stenosis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 9, 2019</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Anatomic Success</measure>
    <time_frame>At the completion of the index procedure</time_frame>
    <description>Defined as the angiographic percentage of stenosis post procedure as &lt;30%</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Technical Success of the Device</measure>
    <time_frame>At the index procedure</time_frame>
    <description>Delivery to the target lesion, deployment of the treatment element, and retrieval</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Success</measure>
    <time_frame>6 Months</time_frame>
    <description>The resumption of normal dialysis for at least one session.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural Success</measure>
    <time_frame>6 Months</time_frame>
    <description>Composite of anatomic and clinical success</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target Lesion Primary Patency</measure>
    <time_frame>6, 9 and 12 Months</time_frame>
    <description>The time interval of uninterrupted patency from initial study treatment to the next thrombosis or intervention performed on the target lesion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Circuit Primary Patency</measure>
    <time_frame>6, 9, and Months</time_frame>
    <description>The time interval from initial study treatment to the next access thrombosis or intervention performed within the vascular access circuit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assisted Primary Patency</measure>
    <time_frame>6, 9, and 12 Months</time_frame>
    <description>The time interval from initial study treatment to occlusion (thrombosis) of the vascular access circuit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Access Secondary Patency</measure>
    <time_frame>6, 9, and 12 Months</time_frame>
    <description>The time interval from initial study treatment to abandonment of the vascular access circuit.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Peripheral Artery Disease</condition>
  <condition>Arteriovenous Fistula Stenosis</condition>
  <condition>Arteriovenous Graft Stenosis</condition>
  <arm_group>
    <arm_group_label>FLEX Vessel Prep followed by angioplasty</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FLEX Vessel Prep System followed by angioplasty</intervention_name>
    <description>Eligible Arteriovenous Fistula (AVF)/Arteriovenous Graft (AVG) will be treated with the FLEX Vessel Prep system followed by angioplasty.</description>
    <arm_group_label>FLEX Vessel Prep followed by angioplasty</arm_group_label>
    <other_name>Balloon Angioplasty</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Arteriovenous Fistula or Arteriovenous Graft Stenosis, eligible for
        FLEX/Angioplasty treatment.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Hemodialysis patient currently scheduled to undergo an intervention of their
             arteriovenous fistula or graft due to clinical or hemodynamic abnormalities.

          2. The patient is â‰¥18 years of age. Patient is legally competent, has been informed of
             the study, voluntarily agrees to participate, and has signed the inform consent form.

          3. The patient has a reasonable expectation of remaining on hemodialysis for 12 months.

          4. The patient understands the study and is willing and able to comply with follow-up
             requirements.

          5. The patient is willing to provide informed consent.

        Exclusion Criteria:

          1. The patient has a known or suspected systemic infection.

          2. The patient has a known or suspected infection of the hemodialysis graft.

          3. The patient has an untreatable allergy to radiographic contrast material.

          4. In the opinion of the operating physician, the patient's hemodialysis access is
             unsuitable for endovascular treatment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Aruny, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dialysis Access Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Katy Feeny</last_name>
    <phone>7632962027</phone>
    <email>KFeeny@venturemedgroup.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>FirstHealth Moore Regional Hospital</name>
      <address>
        <city>Pinehurst</city>
        <state>North Carolina</state>
        <zip>28374</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dialysis Access Institute</name>
      <address>
        <city>Orangeburg</city>
        <state>South Carolina</state>
        <zip>29118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>August 23, 2019</study_first_submitted>
  <study_first_submitted_qc>August 23, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 28, 2019</study_first_posted>
  <last_update_submitted>October 10, 2019</last_update_submitted>
  <last_update_submitted_qc>October 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Arteriovenous Fistula</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
    <mesh_term>Fistula</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

